CDC and Retail Health Clinic Leaders Explore Improving Prevention, Surveillance and Emergenc...(ccording to president of the institute Y...),Health
Navigation Links
CDC and Retail Health Clinic Leaders Explore Improving Prevention, Surveillance and Emergency Response
Date:4/15/2008
ccording to president of the institute Yaneer Bar-Yam, Ph.D. "Their distinct capabilities complement those of traditional providers."
Bradley A. Perkins, Chief Strategy and Innovation Officer for CDC adds, "I am excited and optimistic about the potential for collaborating with CCA to increase access to preventive services for the nation's population routinely as well as in times of crisis."
'/>"/>
| SOURCE Convenient Care Association Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets
2. NFL-Themed Milk Touches Down in Schools and Retail Grocery Stores
3. Retailers Welcome Senate Passage of Mental Health Parity Bill, Urge House to Adopt Senate Version at Subcommittee Markup
4. New Health Corp. Announces the Addition of Stop & Shop and Giant Supermarkets to its Retail Outlets
5. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
6. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
7. Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia
8. Houston Employers Hear New Research That Supports the Case for Retail Clinics
9. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
10. ManHunt2 Video Game: Blasted for Linking Mental Illness to Violence; Retailers Asked Not to Sell Based on Public Health Concern
11. Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics
Post Your Comments:
(Date:11/23/2009)...ty of Michigan determined that only 663,000 of the...s C virus (HCV) infection received antiviral thera...to be declining, in part because only half of the ...ng trend continues, by 2030 less than 15% of liver...viral therapy. This study, the first to analyze n...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ok for the high cost of drug advertising that does...ed by a University of British Columbia health poli...the Archives of Internal Medicine , examined the ...ug also known by the trade name Plavix used to pre... drug was selected to study the impact of advertis...
(Date:11/23/2009)... suffering from women,s hair loss for almost ten y...he,s sharing her progress and the secret behind he...e release of her video diaries which include a dir...reatment. , (PRWeb UK) No...Zsanett Siklosi has released the video diaries tha...
(Date:11/23/2009)...n might ease the problem, researchers say , ...bottle up their anger over unfair treatment at wor...dy indicates. , Men who consistently failed to ...low worker or supervisor were more than twice as l...se as those who vented their anger, claims a repor...
Breaking Medicine News(10 mins):Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3[0] Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US[0] AUDIO from Medialink and Pfizer Inc.: Reduce Holiday Stress to Help Ease Fibromyalgia[1] Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study[1] Women's Hair Loss Treatment Results Captured on Video to Inspire Others[0] Stifled Anger at Work Doubles Men's Risk for Heart Attack
...opene, other nutrients no shield against prostate ...14 (HealthDay News) -- Men who,ve been adding vita...ts to cut their risk of prostate cancer may need t...odds of prostate malignancy -- findings that are i...
...T LAKE CITY, Sept. 14 Dynatronics,Corporation (Na...th quarter,and fiscal year ended June 30, 2007. Ne...943 ($.02 per share), compared to $39,101 ($.00 pe...r the year ended June 30, 2007 were $17,837,104, c...
...NDALE, Mich., Sept. 14 Nearly 300 of,Detroit,s mo...f art to be,auctioned at the twelfth annual "ART W...5:00 p.m. on Sunday, September 23, 2007 at The Rit...tioneer Jim Miller, hors d,oeuvres, a cash bar, va...
...ANN ARBOR, Mich.---Using atom-level imaging techni...aled important structural details of an enzyme sys...ole in helping the body efficiently break down man...es. , The system involves two proteins that work ...
...Many sets of guidelines and regulations, and great...l researchers encounter if they want to use previo...arch. For one thing, this makes it extremely comp... (CBE), together with leading biobank researchers,...
...g-Term Outlook More Favorable as Drugs from Eli Li... 2016, According to a New Report ...pt. 12 Decision Resources, one of the,world,s lea...Astellas,s Flomax/Harnal, combined with the limite...
Other Medicine News:Health News:Tomato Diet Can't Guarantee Prostate Health: Study 2Health News:Tomato Diet Can't Guarantee Prostate Health: Study 3Health News:Tomato Diet Can't Guarantee Prostate Health: Study 4Health News:Dynatronics Announces Strong Fourth Quarter Profit 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 3Health News:Revealing the workings of 'Mother Nature's blowtorch' 2Health News:Long-awaited international ethical guidelines for biobank researchers 2Health News:Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs 2Tomato Diet Can't Guarantee Prostate Health: StudyDynatronics Announces Strong Fourth Quarter ProfitLocal Artists Unite in the Fight Against AIDSRevealing the workings of 'Mother Nature's blowtorch'Long-awaited international ethical guidelines for biobank researchersPatent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs
(Date:11/23/2009)...wswire-FirstCall/-- LexiconPharmaceuticals,Inc. (N...sPhase2clinicalstudywith LX1031 inpatientswithnon-...ntedatGASTRO2009inLondonthisweek.Resultsfromthestu...,willbepresentedbyDr. PhilipM.Brown ,Lexicon,sseni...2009at2:30pmlocaltimeatthesessionentitled,"Therape...
(Date:11/23/2009)...ire-FirstCall/--WoundManagementTechnologies,Inc.,(...cialtymedicalproducts,announcedthatithasfileditQ32...agementbusinessupdatetoillustratethedevelopmentsdu...ed33.5%to$102,926vs.Q32008salesof$77,084. , S...vs.Q32008shareholderequityof$(321,257) , Tota...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq: ANSV...chardhaveagreedtojointheAnesivaboardofdirectorsfol...ndArcionTherapeutics.Completionofthemergerissubjec...uslyannouncedAnesiva2009AnnualMeetingofStockholder...Point,Suite107A,SouthSanFrancisco,California,among...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 1OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 2OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 3Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 1Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 2Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 3Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 4Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 1Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 2[0] Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009[0] Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update[0] Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger
...w Subset Analyses To Be Presented --, SAN FRANCISC...tion, Inc. today announced that data from the Comp...heimer,s disease will be,presented for the first t...f Neurology,s 59th Annual Meeting in Boston on Thu...ntation will include new,data from both the mild a...
...R--(BUSINESS WIRE)--Apr 24, 2007 - Ceragenix Pharm...ive results from its,post-clearance marketing stud...ivate(R) cream, a mid-strength topical steroid in ...tis (AD)., The study, which took place at five cen... patients receiving treatment with,Cutivate(R) and...
Other Medicine Technology:Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 2Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 3Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 4Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 5Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 6...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |